Francesco Luzza

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (13)

Rocco Spagnuolo

ITALY

View details

Ludovico MONTEBIANCO ABENAVOLI

Associate professor

Università degli Studi Mediterranea di Reggio Calabria

ITALY

View details

Antonio Leo

ITALY

View details

Emidio Scarpellini

BELGIUM

View details

Luigi Boccuto

UNITED STATES

View details

Bruno TILOCCA

University of Hohenheim

GERMANY

View details

Giorgio Sesti

Professor of Internal Medicine

Sapienza University of Rome

ITALY

View details

Isabella Aquila

ITALY

View details

Massimo Borelli

Magna Graecia University

ITALY

View details

Paola Roncada

Full professor

Università degli Studi Magna Graecia di Catanzaro Dipartimento di Scienze della Salute

ITALY

View details

Ivan Capobianco

University College Cork

IRELAND

View details

Daniela Foti

Full Professor of Clinical Pathology

Università degli Studi Mediterranea di Reggio Calabria

ITALY

View details

Domenico Laganà

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Francesco Luzza

Research Interests

Explore related searches

Contact this professor

Articles (20)

Impact of Endoscopic Band Ligation on Gastric Complications Associated with Portal Hypertension

Use of Metabolic Scores and Lipid Ratios to Predict Metabolic Dysfunction-Associated Steatotic Liver Disease Onset in Patients with Inflammatory Bowel Diseases

The Diagnosis of Wilkie’s Syndrome Associated with Nutcracker Syndrome: A Case Report and Literature Review

Change in Diagnosis of Helicobacter pylori Infection in the Treatment-Failure Era

The Many Faces of Metabolic Dysfunction-Associated Fatty Liver Disease Treatment: From the Mediterranean Diet to Fecal Microbiota Transplantation

Use of Non-Invasive Biomarkers and Clinical Scores to Predict the Complications of Liver Cirrhosis: A Bicentric Experience

Long-Term Effectiveness and Safety of Ustekinumab in Crohn’s Disease: Results from a Large Real-Life Cohort Study

Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients with Inflammatory Bowel Diseases: A Pilot Study

Gut Microbiota and Critically Ill Patients: Immunity and Its Modulation via Probiotics and Immunonutrition

Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome

Gut Microbiota and Liver Transplantation: Immune Mechanisms behind the Rejection

Obesity and overweight are linked to increased sodium‐glucose cotransporter 1 and glucose transporter 5 levels in duodenum

Ultrasound Prevalence and Clinical Features of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Diseases: A Real-Life Cross-Sectional Study

Comparison of Performances of Adalimumab Biosimilars SB5, ABP501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study

Efficacy of a new nutraceutical formulation: L-tryptophan, probiotics, charcoal, chamomile, mint, and licorice (COLONIR<sup>®</sup>) in the improvement of gastrointestinal symptoms in subjects with irritable bowel syndrome

Liver injury associated with high value of D-dimer plasmatic level in COVID-19 patients

Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn’s disease: results from an Italian multicenter study

Liver Damage and Impaired Coagulation in COVID-19 Patients: A Case Series

Gut Microbiota in Non-Alcoholic Fatty Liver Disease Patients with Inflammatory Bowel Diseases: A Complex Interplay

Biologics for Inflammatory Bowel Disease in Clinical Practice: A Calabria (Southern Italy) Prospective Pharmacovigilance Study

Collaborators (13)

Rocco Spagnuolo

Ludovico MONTEBIANCO ABENAVOLI

Antonio Leo

Emidio Scarpellini

Luigi Boccuto

Bruno TILOCCA

Giorgio Sesti

Isabella Aquila

Massimo Borelli

Paola Roncada

Ivan Capobianco

Daniela Foti

Domenico Laganà

Make your next move.